Saphnelo Injection, Solution
Product Images NDC 0310-3040

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Saphnelo (NDC 0310-3040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_1 (Figure 1)

The text presents a graph showing the Proportion of BICLA responders with an error margin represented by +/- SE for patients treated with anifrolumab 300mg (N=180) and placebo (N=182) over time in weeks. There is no data available for week 0. It is indicated that the same patients may not have responded at each time point.*

FDA Label Image

Single Dose Vial Carton Sales 300mg2ml

NDC 0310-3040-00 is a single-dose vial of Z Saphnelo™ (anifrolumab-fnia) which is meant for Intravenous Infusion After Dilution. It is important to dilute it before use and not to shake or freeze it. The unused portion of the vial must be discarded. It is advised to store it at a temperature of 2°C to 8°C (36°F to 46°F) and keep the vial in its original carton to protect it from the light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.